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Abstract
Background: Brucellosis is known to cause debilitating conditions if not promptly treated. In some rural
areas of Tanzania however, practitioners give evidence of seeing brucellosis cases with symptoms of long
duration. The purpose of this study was to establish health-seeking behaviour of human brucellosis cases
in rural Tanzania and explore the most feasible ways to improve it.
Methods: This was designed as a longitudinal study. Socio-demographic, clinical and laboratory data were
collected from patients who reported to selected hospitals in rural northern Tanzania between June 2002
and April 2003. All patients with conditions suspicious of brucellosis on the basis of preliminary clinical
examination and history were enrolled into the study as brucellosis suspects. Blood samples were taken
and tested for brucellosis using the Rose-Bengal Plate Test (RBPT) and other agglutination tests available
at the health facilities and the competitive ELISA (c-ELISA) test at the Veterinary Laboratory Agencies
(VLA) in the UK. All suspects who tested positive with the c-ELISA test were regarded as brucellosis cases.
A follow-up of 49 cases was made to collect data on health-seeking behaviour of human brucellosis cases.
Results: The majority of cases 87.7% gave a history of going to hospital as the first point of care, 10.2%
purchased drugs from a nearby drug shop before going to hospital and 2% went to a local traditional healer
first. Brucellosis cases delayed going to hospital with a median delay time of 90 days, and with 20% of the
cases presenting to hospitals more than a year after the onset of symptoms. Distance to the hospital,
keeping animals and knowledge of brucellosis were significantly associated with patient delay to present
to hospital.
Conclusion: More efforts need to be put on improving the accessibility of health facilities to the rural
poor people who succumb to most of the diseases including zoonoses. Health education on brucellosis in
Tanzania should also stress the importance of early presentation to hospitals for prompt treatment.
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Background
Brucellosis is caused by gram-negative bacilli, of the genus
Brucella (Brucella abortus, B. suis, B. melitensis and B. canis)
[1]. The most common clinical features of brucellosis
include fever, fatigue, headache, sweating, joint pain, loss
of appetite, muscular pain, lumber pain, weight loss,
hepatomegally, splenomegally and arthritis. The multiple
and non-specific features of brucellosis contribute to dif-
ficulties in the diagnosis of brucellosis in areas where dis-
eases with similar clinical features such as malaria,
tuberculosis, typhoid and joint diseases co-exist [1,2].
Although generally speaking, any member of the public is
at risk of getting brucellosis through consumption of
poorly prepared dairy products in the form of meat, milk,
cheese and butter, certain occupations such as veterinari-
ans, butchers, abattoir workers, meat inspectors, farmers
and those working in meat packing and dairy processing
industries are known to be at a greater risk [3,4].
In many sub-Sahara African countries, febrile or flu-like
conditions with similar manifestations occur commonly
and have significantly contributed to difficulties in the
diagnoses of such diseases as brucellosis, typhoid,
malaria, amoeba and tuberculosis [5,6]. In Narok, Kenya,
12% of flu-like patients were diagnosed using the RBPT as
brucellosis patients and 40% typhoid patients [7]. In
Kampala, Uganda, of patients with joint pain, general
malaise, and/or constant headache, 73% were found to be
suffering from malaria and 13.3% from brucellosis [5].
Clinical features and laboratory investigation form the
basis for the diagnosis of brucellosis in humans [8]. The
definitive diagnosis of brucellosis is by culture and isola-
tion of the causative organisms. However, the procedure
requires special media, takes several weeks of incubation
and has low sensitivity [9,10]. The laboratory diagnosis of
brucellosis therefore often depends on serologic tests.
These include the Serum Agglutination Tests (SAT) [11],
the Complement Fixation Test [12], the Fluoroscent
Polarization Assay [13,14] and the Enzyme-Linked immu-
nosorbent Assays (ELISA) tests [15]. Other tests include
the radioimmunoassay [16], the indirect immunofluores-
cence assay [17], and the 2-mercaptoethanol test (2ME)
[18].
In the sub-acute or chronic phase of brucellosis however,
the agglutination tests may be particularly difficult to
interpret or may be negative and other tests need to be
done to confirm the results. This is because the serum
agglutination test depends very much on the presence of
IgM immunoglobulin that could be low or absent in
chronic and sub-acute states. This also explains why the
SAT is negative during the incubation period and follow-
ing abortion [19].
The c-ELISA test for the detection of serum antibodies to
the organisms of the genus Brucella has been shown to be
a suitable test for human brucellosis [15]. The c-ELISA test
uses a monoclonal antibody (mAb) specific for a com-
mon and repeating epitope on the polysaccharide portion
of the smooth lipopolysaccharide molecule of Brucella to
compete with antibody in the sample. This results in an
assay with higher specificity than other assays because it
frequently eliminates cross-reactions with other antigens
while retaining its high sensitivity. The c-ELISA test there-
fore could be adopted as the confirmatory test for human
brucellosis [15].
Most of the hospital laboratories in rural sub-Saharan
Africa have limited capacity for the diagnosis of brucello-
sis. Brucellosis is commonly diagnosed after failure to
respond to malaria, typhoid or tuberculosis treatments
[20,21]. In the current study, it was observed that serolog-
ical diagnosis was only conducted in districts or desig-
nated district hospitals. In Kenya, local clinics were
conducting the RBPT, but additional tests such as the SAT
were only conducted in central veterinary or medical test-
ing facilities [7,20]. Most of these facilities are not easily
accessible to the majority of people in rural areas of Africa
due to their geographical location and poor infrastructure.
Brucellosis caused by B. melitensis is the most important
clinically apparent disease in humans and is the one usu-
ally associated with occupational exposure or consump-
tion of poorly prepared dairy products [22], followed by
infection with B. abortus and by B. suis. Because of its
greater severity, infections with B. melitensis are generally
considered more likely to be diagnosed than infection
with other Brucella species [23].
Health-seeking behaviour of patients suffering from infec-
tious and non-infectious diseases have been evaluated in
many parts of Africa. These include those suffering from
tuberculosis [24-27], sleeping sickness [28] and non-
infectious diseases [29]. Factors that determine when
patients get hospital treatment vary from the patients'
own reasons to those due to health providers. Patient fac-
tors include expectations that the symptoms might
improve, visit to local traditional healer and self medica-
tion from a nearby drug shop or private clinic.
Other factors that have been documented as causing delay
in patients seeking health facilities' treatment include the
distance to the nearest health facility and socio-economic
status. Some households are far from hospitals and poor
infrastructure make accessibility to health care difficult. In
areas where there is transportation, affordability of the
costs of transport made patients unable to present to hos-
pitals in time. Factors related to health provider included
poor referral system, high work load and diagnostic diffi-
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culties [24-28]. The purpose of this study was to investi-
gate factors that play role in determining when brucellosis
cases present to hospital, where they go first to seek treat-
ment and try to come up with most feasible solutions.
Methods
Study area
The study was conducted in the northern regions of Aru-
sha and Manyara, Tanzania. Districts involved with the
study included Mbulu, Babati and Hanang in Manyara
region and Ngorongoro and Karatu in Arusha region (Fig-
ure 1). Hospitals involved with the study included Babati
and Dareda hospitals in Babati district, Mbulu and
Hydom hospitals in Mbulu district, Katesh hospital in
Hanang district, Karatu Lutheran hospital in Karatu dis-
trict and Endulen and Wasso hospitals in Ngorongoro dis-
trict.
Study design, laboratory investigation and cases enrolment
This was designed as a longitudinal study. Any patient
who presented to the hospitals between June 2002 and
April 2003 with any of the clinical features including
fever, headache, joint pain, malaise, backache, fatigue and
loss of appetite was enrolled into the study by a practi-
The map of Tanzania showing the study areaFigure 1
The map of Tanzania showing the study area.
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tioner attending the patient as a suspected brucellosis
case. Other information such as personal particulars, data
on clinical history, level of education, whether they keep
livestock, economic status etc. were also recorded by an
attending practitioner. Laboratory investigations at the
health facilities using the rapid agglutination tests includ-
ing the RBPT were conducted and patients were managed
according to the clinical features and laboratory results.
An aliquot of each sample was stored for c-ELISA test at
the VLA in the UK. Any patient with any two or more of
the clinical features such as fever, headache, joint pain,
waist pain, backache, malaise, fatigue and tested positive
with the c-ELISA test at the VLA was defined as a brucello-
sis case.
Distance to the nearest hospital
The GIS coordinates of the households and of the hospi-
tals were recorded from a hand-held Garmin® GPS
machine. All coordinates were then transferred to Excel
2003 spreadsheets (Microsoft Corporation, Redmond,
Washington, USA) and the distance between the hospitals
and the households calculated in kilometers using ArcGIS
9 software (ESRI, Redlands, California).
Patient delay
Due to time constraints and difficulties in accessing bru-
cellosis cases, the principal investigator was able to collect
data on health-seeking behavior for 49 cases. Patient delay
was defined as the time interval between the development
of first symptoms of brucellosis to the time the case pre-
sented to hospital. Thirty days since the onset of first
symptoms was taken as the cut-off point during which any
patient with brucellosis symptoms was supposed to have
presented to hospital for diagnosis and treatment [2]. All
cases who presented to hospital 30 days or more after the
onset of the first symptoms were defined as delayed going
to hospital and those who presented earlier than 30 days
not delayed.
Data analysis
Data were entered on Excel 2003 spreadsheets (Microsoft
Corporation, Redmond, Washington, USA) and analyzed
using Minitab version 1.4 (Minitab Inc. 2000, Release 14
for Windows, State College, Pennsylvania). Chi-square
tests were used to analyze all data and Fisher's exact test
was used where 2 × 2 tabular results were obtained with
any expected counts of less than 5. A p-value of < 0.05 was
considered statistically significant. In multivariate analy-
sis, Minitab version 1.4 was used to run logistic regression
analysis. A backward stepwise method was used to find
the best suite of variables (model simplification). The
least significant variables were considered first for
removal. Any variables that caused an insignificant
increase in deviance on removal from the model was left
out of the model while the variable that caused a signifi-
cant increase in deviance on removal was retained in the
model.
Ethical issues
The study was peer reviewed and cleared for ethics by the
Medical Research Coordinating Committee of the
National Institute for Medical Research in the Republic of
Tanzania. Verbal consent was also sought from all the
patients before they were enrolled into the study and
before any diagnostic procedure was conducted.
Results
Of the 1586 samples that were collected from suspected
brucellosis patients over a ten-month period and sent to
VLA for the c-ELISA test, 98 (6.2%) tested positive for bru-
cellosis. These 98 cases were considered to be confirmed
positive cases.
Patient delay and treatment delay
Of the 49 cases whose data on health-seeking behavior
was available, 11 (22.4%) went to hospital within one
month after the onset of symptoms, 10 (20.4%) between
one and three months, 12 (24.5%) between three and six
months, six (12.2%) between six months and one year
and 10 (20%) sought treatment more than a year after the
onset of symptoms (Figure 2). Using the cut-off point of
30 days as the time that a case was supposed to have pre-
sented to hospital, the median patient delay time was 90
days (mean, 157. 3 days). Health system delay was a result
of false negative results causing a failure to diagnose 22
(44.8%) cases of brucellosis on their first visits to hospi-
tals.
Site of first treatment
The majority of brucellosis cases 43 (87.7%) gave a his-
tory of going to hospital as the first point of care, five
(10.2%) purchased drugs from a nearby drug shop before
The time brucellosis cases presented to hospital after devel-opment of first symptomsFigure 2
The time brucellosis cases presented to hospital after devel-
opment of first symptoms.
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going to hospital and one patient (2%) went to a local tra-
ditional healer first
Factors responsible for patient delays
The mean distance between the households of cases and
hospitals was determined as 8.3 km, (median, 7.1 km).
Univariate analysis showed that age of the case, distance
to hospital, economic status, whether the household
keeps livestock and knowledge of brucellosis were signifi-
cantly associated with patient delay in presentation to
hospitals (Table 1). In the multivariate analysis, patient
delay was found to be most associated with distance to the
nearest hospital, knowledge of brucellosis and if the
household of a case keeps livestock (likelihood ratio p-
value 0.03) (Table 2).
Discussion
Cases that live far from hospitals were found to have a
higher chance of delaying going to hospital compared to
those living close to hospitals. In the study area, many
households are far from health facilities and the infra-
structures are still poor. Delay to present to hospital is
therefore associated with how accessible the hospitals are.
The government should try with little resources available
to bring health care closer to the people particularly those
in rural areas who make the majority of the population
[30] and who form the workforce of the country.
Cases keeping livestock were also found to delay going to
hospital. Possibly it was difficult for them to leave their
livestock with nobody to attend to or they were too occu-
pied with caring for the livestock causing them to have
hardly any time to present to hospital. They probably pre-
sented to hospital when they were less engaged with car-
ing for livestock. Since the majority of the people living in
the study area keep livestock [31], awareness on the
importance of going to hospital early requires considera-
ble resources and commitment.
Cases with the knowledge of how brucellosis is transmit-
ted and how it manifests also delayed going to hospital.
Brucellosis is known to run a chronic course with some of
the symptoms that may not be very severe at the onset and
a fatality rate of 0.2% if untreated [32-34]. This could
explain the reason why cases with the knowledge of bru-
cellosis delayed going to hospital.
In the present study, the majority of brucellosis cases pre-
sented to hospital with a long history of symptoms. Some
of the cases had been to hospital several times and had
received treatment for other diseases such as malaria
before being diagnosed as suffering from brucellosis. It
became apparent that persistence of symptoms rather
than the severity of the symptoms was the main com-
plaint of brucellosis cases.
As a result of false negative results, 22 (44.8%) brucellosis
cases were not diagnosed at the hospitals on their first
presentations. These were treated for other diseases such
as malaria which is much more common in the study area
than brucellosis and hence they continued to suffer from
brucellosis. The delay to present to hospitals could have
caused brucellosis to turn into chronic form which could
not be detected by the agglutinations tests performed at
the hospitals [19].
Table 1: Univariate analysis of factors responsible for patient delay
95% confidence 
interval
Variable Coefficients Std. Error Odds 
ratio
Lower Upper Likelihood 
ratio p-value
Keeps livestock 1.61 0.63 5 1.45 17.27 0.003†
Distance to village centre 0.13 0.11 1.14 0.92 1.41 0.20
Religion 0.41 0.91 1.50 0.25 8.98 0.65
Tribe 0.69 0.71 2 0.50 7.99 0.14
1.25 0.80 3.50 0.73 16.85
Distance to hospital 0.11 0.06 3.12 1.00 4.26 0.02†
Gender 0.69 0.43 2 0.86 4.67 0.09
Age 0.02 0.01 1.02 1.01 1.04 0.001†
Knowledge of brucellosis 1.50 0.78 4.50 0.97 20.83 0.03†
Level of education 1.25 0.80 3.50 0.73 16.85 0.09
Economic status 1.47 0.64 4.33 1.23 15.21 0.02†
0.69 0.87 2 0.37 10.92
If any member of the household suffered from brucellosis 1.09 0.82 3 0.61 14.86 0.15
† – Variables included in multivariate analysis
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The majority of the cases (87.8%) first sought treatment at
a hospital and a few either treated themselves at home by
buying medicine from a nearby drug shop (10.2%) or
attended to a local traditional healer (2%). In the study
area, a purely private health system has not been fully
established, the majority of patients therefore, go to pub-
lic hospitals which are run by government or religious
groups (missionary hospitals). It was hence unlikely for
cases to be delayed in private commercial health providers
such as those found in urban areas. Studies conducted
elsewhere on the causes of patients suffering form differ-
ent to delay to present to hospital established that patients
spent longer periods seeking treatment from traditional
healers, profit making or private hospitals or delayed due
to poor referral systems. This caused their financial
resources to be wasted at times without getting proper
treatment [24,35,36].
Conclusion
More efforts need to be put on improving the accessibility
of health facilities to the rural poor people who succumb
to most of the diseases including zoonoses. Health educa-
tion to the public should also include emphasis on
patients to present to hospital early when chronic clinical
features and complications have not developed as late
presentation may carry poor prognosis even after treat-
ment.
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